Search results
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Benzinga via Yahoo Finance· 1 week agoWednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling...
COVID aside, vaccines and asthma drugs deliver strong quarter for GSK
WFMZ Eastern Pennsylvania and Western New Jersey· 1 week agoThe company also said General Medicines, particularly Trelegy, performed better than expected. GSK expects first half 2024 year over year sales growth to be higher than second ...
GSK raises profit outlook on strong vaccine, HIV drug sales By Reuters
Investing.com· 1 week agoCEO Emma Walmsley's strategy has focussed on vaccines, cancer and infectious diseases and a shift in...
GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance
Zacks via Yahoo Finance· 1 week agoGSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The...
20 Fastest Growing Health Tech Companies in the World
Insider Monkey via Yahoo Finance· 2 weeks agoIn this article, we will be taking a look at the 20 fastest growing health tech companies in the...